🇺🇸 FDA
Pipeline program

MT-7117 Formulation Code C, MT-7117 Placebo

MT-7117-A-302

Phase 3 small_molecule active

Quick answer

MT-7117 Formulation Code C, MT-7117 Placebo for Erythropoietic Protoporphyria or X-Linked Protoporphyria is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Erythropoietic Protoporphyria or X-Linked Protoporphyria
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials